Drug Research

Lupin Ltd, India’s third largest drug maker, will buy a portfolio of 21 generic brands from Osaka-based Shionogi & Co. Ltd at the cost of US $150 million. August 3, 2016: The move will help the company to strengthen. ...

Pfizer is the latest addition to an expanding list of drug makers found deviating from good manufacturing practices in India.In the last week of June,a high profile team drawn from world's four leading regulators identified a number of deficiencies...

A new set of community-produced biological network models has been shown to allow a deeper understanding of the mechanisms underlying a range of diseases. The models, of which earlier versions have been described in detail in...

Researchers at the Johns Hopkins Kimmel Cancer Center say they have developed a system that uses transformed human stem cells to speed up screening of existing drugs that might work against rare brain and other cancers. ...

Sun Pharma, India's largest drug company has rolled out InfuSMART the first ever ready to administer version of anti cancer drug gemcitabine in six countries of Europe including Netherlands, UK, Spain, Germany, Italy and France.  The...

Legislation is being put into place, but it is still essential that we all play a participative role in the continued fight to protect the patients that rely on our product. Introduction The issue of counterfeit pharmaceutical product is growing...

“Diagnosis cancer” – this is a life-changing moment for many people. After cardiovascular diseases, cancer remains the next most common cause of death worldwide. In 2012, around 8.2 million people died as a result of cancer. According to the...